FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Stevens

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Microbial Sensitivity Tests

Co-author Network

Publications

TOP 3
David A Stevens
Mycologic catastrophe.
David A Stevens
Reflections on the approach to treatment of a mycologic disaster.
Marife Martinez; Vicky Chen; Karl V Clemons; Kelsey Hamilton; Ann-Jay Tong; David A Stevens
Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Stevens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David A Stevens
Mycologic catastrophe.
Antimicrobial agents and chemotherapy 2013;57(6):2904.
2013: David A Stevens
Reflections on the approach to treatment of a mycologic disaster.
Antimicrobial agents and chemotherapy 2013;57(4):1567-72.
2013: Marife Martinez; Vicky Chen; Karl V Clemons; Kelsey Hamilton; Ann-Jay Tong; David A Stevens
Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2013;57(4):1882-7.
2012: David A Stevens
Advances in systemic antifungal therapy.
Clinics in dermatology 2012;30(6):657-61.
2012: Karl V Clemons; Julie A Schwartz; David A Stevens
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
Antimicrobial agents and chemotherapy 2012;56(8):4439-49.
2012: Karl V Clemons; David A Stevens
Orogastrointestinal model of mucosal and disseminated candidiasis.
Methods in molecular biology (Clifton, N.J.) 2012;845():557-67.
2011: Joe L Hsu; Margaret Lin; Stephen J Ruoss; Natalie D Bower; Mark Holodniy; David A Stevens
Diagnosing invasive fungal disease in critically ill patients.
Critical reviews in microbiology 2011;37(4):277-312.
2011: Jata Shankar; Angela Restrepo; Karl V Clemons; David A Stevens
Hormones and the resistance of women to paracoccidioidomycosis.
Clinical microbiology reviews 2011;24(2):296-313.
2011: David A Stevens; Karl V Clemons; Min Liu
Developing a vaccine against aspergillosis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2011;49 Suppl 1():S170-6.
2011: Min Liu; Karl V Clemons; Marty Bigos; Izabela Medovarska; Elmer Brummer; David A Stevens
Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection.
Vaccine 2011;29(9):1745-53.
2011: David A Stevens; George L Melikian
Aspergillosis in the 'nonimmunocompromised' host.
Immunological investigations 2011;40(7-8):751-66.
2010: Karl V Clemons; Juha H Salonen; Jouni Issakainen; Jukka Nikoskelainen; Michael J McCullough; Jacks J Jorge; David A Stevens
Molecular epidemiology of Saccharomyces cerevisiae in an immunocompromised host unit.
Diagnostic microbiology and infectious disease 2010;68(3):220-7.
2010: Elmer Brummer; Mary A Antonysamy; Lakshmi Bythadka; Gary W Gullikson; David A Stevens
Effect of 3M-003, an imidazoquinoline, on phagocyte candidacidal activity directly and via induction of peripheral blood mononuclear cell cytokines.
FEMS immunology and medical microbiology 2010;59(1):81-9.
2010: James Kim; Jean Y Tang; Ruoyu Gong; Jynho Kim; John J Lee; Karl V Clemons; Curtis R Chong; Kris S Chang; Mark Fereshteh; Dale Gardner; Tannishtha Reya; Jun O Liu; Ervin H Epstein; David A Stevens; Philip A Beachy
Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth.
Cancer cell 2010;17(4):388-99.
2010: Elmer Brummer; David A Stevens
Collectins and fungal pathogens: roles of surfactant proteins and mannose binding lectin in host resistance.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2010;48(1):16-28.
2009: Eveline C van Asbeck; Karl V Clemons; Angela N Markham; David A Stevens
Correlation of restriction fragment length polymorphism genotyping with internal transcribed spacer sequence, randomly amplified polymorphic DNA and multilocus sequence groupings for Candida parapsilosis.
Mycoses 2009;52(6):493-8.
2009: David A Stevens; Karl V Clemons; Hillel B Levine; Demosthenes Pappagianis; Ellen Jo Baron; John R Hamilton; Stan Deresinski; Nancy Johnson
Expert opinion: what to do when there is Coccidioides exposure in a laboratory.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(6):919-23.
2009: Jomar Patrício Monteiro; Karl V Clemons; Laurence F Mirels; John A Coller; Thomas D Wu; Jata Shankar; Catalina R Lopes; David A Stevens
Genomic DNA microarray comparison of gene expression patterns in Paracoccidioides brasiliensis mycelia and yeasts in vitro.
Microbiology (Reading, England) 2009;155(Pt 8):2795-808.
2009: David A Stevens; John R Hamilton; Nancy Johnson; Kwang Kyu Kim; Jung-Sook Lee
Halomonas, a newly recognized human pathogen causing infections and contamination in a dialysis center: three new species.
Medicine 2009;88(4):244-9.
2009: Javier Capilla; Karl V Clemons; Min Liu; Hillel B Levine; David A Stevens
Saccharomyces cerevisiae as a vaccine against coccidioidomycosis.
Vaccine 2009;27(27):3662-8.
2009: David A Stevens
Frequency of paradoxical effect with caspofungin in Candida albicans.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2009;28(6):717.
2009: Karl V Clemons; Javier Capilla; Raymond A Sobel; Marife Martinez; Ann-Jay Tong; David A Stevens
Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits.
Antimicrobial agents and chemotherapy 2009;53(5):1858-62.
2009: Eveline C van Asbeck; Karl V Clemons; David A Stevens
Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.
Critical reviews in microbiology 2009;35(4):283-309.
2009: David A Stevens
Clinical aspergillosis for basic scientists.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47 Suppl 1():S1-4.
2009: Karl V Clemons; David A Stevens
Conventional or molecular measurement of Aspergillus load.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47 Suppl 1():S132-7.
2008: Eveline van Asbeck; Karl V Clemons; Marife Martinez; Ann-Jay Tong; David A Stevens
Significant differences in drug susceptibility among species in the Candida parapsilosis group.
Diagnostic microbiology and infectious disease 2008;62(1):106-9.
2008: David A Stevens
A possible mechanism for synergy between antifungal therapy and immune defenses.
The Journal of infectious diseases 2008;198(2):159-62.
2008: Adi Koneti; Michael J Linke; Elmer Brummer; David A Stevens
Evasion of innate immune responses: evidence for mannose binding lectin inhibition of tumor necrosis factor alpha production by macrophages in response to Blastomyces dermatitidis.
Infection and immunity 2008;76(3):994-1002.
2008: THOMAS WALSH; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne H van Burik; John R Wingard; Thomas Patterson
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(3):327-60.
2007: Javier Capilla; Karl V Clemons; David A Stevens
Animal models: an important tool in mycology.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2007;45(8):657-84.
2007: Eveline C van Asbeck; Yhu-Chering Huang; Angela N Markham; Karl V Clemons; David A Stevens
Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies.
Mycopathologia 2007;164(6):287-93.
2007: Elmer Brummer; Javier Capilla; Lakshmi Bythadka; David A Stevens
Production of IL-6, in contrast to other cytokines and chemokines, in macrophage innate immune responses: effect of serum and fungal (Blastomyces) challenge.
Cytokine 2007;39(3):163-70.
2007: Antonino Catanzaro; Gretchen A Cloud; David A Stevens; Bernard E Levine; Paul L Williams; Royce H Johnson; Adrian Rendon; Laurence F Mirels; Jon E Lutz; Melissa Holloway; John N Galgiani
Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(5):562-8.
2007: Javier Capilla; Karl V Clemons; Raymond A Sobel; David A Stevens
Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.
The Journal of antimicrobial chemotherapy 2007;60(3):673-6.
2007: David A Stevens; Adrian Rendon; Veronica Gaona-Flores; Antonino Catanzaro; Gregory M Anstead; Lisa Pedicone; John Graybill
Posaconazole therapy for chronic refractory coccidioidomycosis.
Chest 2007;132(3):952-8.
2007: David A Stevens; Karl V Clemons
Azole therapy of clinical and experimental coccidioidomycosis.
Annals of the New York Academy of Sciences 2007;1111():442-54.
2007: Karl V Clemons; Javier Capilla; David A Stevens
Experimental animal models of coccidioidomycosis.
Annals of the New York Academy of Sciences 2007;1111():208-24.
2007: Perparim Kamberi; Raymond A Sobel; Karl V Clemons; Andreas Waldvogel; Joan M Striebel; Paul L Williams; David A Stevens
Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.
Antimicrobial agents and chemotherapy 2007;51(3):998-1003.
2007: THOMAS WALSH; Issam Raad; Thomas Patterson; Pranatharthi H Chandrasekar; Gerald R Donowitz; Richard Graybill; Reginald E Greene; Ray Hachem; Susan Hadley; Raoul Herbrecht; Amelia Langston; Arnold Louie; Patricia Ribaud; Brahm H Segal; David A Stevens; Jo-Anne H van Burik; Charles S White; Gavin Corcoran; Jagadish Gogate; Gopal Krishna; Lisa Pedicone; Catherine J Hardalo; John R Perfect
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):2-12.
2006: Javier Capilla; Claudia M L Maffei; Karl V Clemons; Raymond A Sobel; David A Stevens
Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2006;44(7):601-10.
2006: David A Stevens; Elmer Brummer; Karl V Clemons
Interferon- gamma as an antifungal.
The Journal of infectious diseases 2006;194 Suppl 1():S33-7.
2006: Elmer Brummer; V Vinoda; David A Stevens
IL-12 induction of resistance to pulmonary blastomycosis.
Cytokine 2006;35(5-6):221-8.
2006: David A Stevens; Masayuki Ichinomiya; Yukako Koshi; Hiroyuki Horiuchi
Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Antimicrobial agents and chemotherapy 2006;50(9):3160-1.
2006: Karl V Clemons; Gloria M Gonzalez; Gaurav Singh; Jackie Imai; Marife Espiritu; Rachana Parmar; David A Stevens
Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.
Antimicrobial agents and chemotherapy 2006;50(8):2650-7.
2006: Madhavi Lekkala; Ann Marie Levine; Michael J Linke; Erika C Crouch; Bruce Linders; Elmer Brummer; David A Stevens
Effect of lung surfactant collectins on bronchoalveolar macrophage interaction with Blastomyces dermatitidis: inhibition of tumor necrosis factor alpha production by surfactant protein D.
Infection and immunity 2006;74(8):4549-56.
2006: Karl V Clemons; David A Stevens
Animal models testing monotherapy versus combination antifungal therapy: lessons learned and future directions.
Current opinion in infectious diseases 2006;19(4):360-4.
2006: Karl V Clemons; Rachana Parmar; Marife Martinez; David A Stevens
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
The Journal of antimicrobial chemotherapy 2006;58(2):466-9.
2006: Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Assessment of the paradoxical effect of caspofungin in therapy of candidiasis.
Antimicrobial agents and chemotherapy 2006;50(4):1293-7.
2006: Jung-Hyun Choi; Elmer Brummer; Young Jun Kang; Patricia P Jones; David A Stevens
Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia.
The Journal of infectious diseases 2006;193(7):1023-8.
2006: K E Zucker; Perparim Kamberi; Raymond A Sobel; G Cloud; Damian N Meli; Karl V Clemons; David A Stevens; Paul L Williams; Stephen Leib
Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.
Clinical and experimental immunology 2006;143(3):458-66.
2006: Karl V Clemons; David A Stevens
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2006;44(1):69-73.
2006: Neelima Kethineni; Elmer Brummer; David A Stevens
Susceptibility to pulmonary blastomycosis in young compared to adult mice: immune deficiencies in young mice.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2006;44(1):51-60.
2005: Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Antimicrobial agents and chemotherapy 2005;49(12):4867-75.
2005: John N Galgiani; Neil M Ampel; Janis E Blair; Antonino Catanzaro; Royce H Johnson; David A Stevens; Paul L Williams
Coccidioidomycosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(9):1217-23.
2005: Elmer Brummer; Neelima Kethineni; David A Stevens
Immunological basis for susceptibility and resistance to pulmonary blastomycosis in mouse strains.
Cytokine 2005;32(1):12-9.
2005: Jackie Imai; Gaurav Singh; Belkys Fernandez; Karl V Clemons; David A Stevens
Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.
The Journal of antimicrobial chemotherapy 2005;56(1):166-71.
2005: Elmer Brummer; J H Choi; David A Stevens
Interaction between conidia, lung macrophages, immunosuppressants, proinflammatory cytokines and transcriptional regulation.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43 Suppl 1():S177-9.
2005: Karl V Clemons; David A Stevens
The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43 Suppl 1():S101-10.
2005: David A Stevens; Theodore C White; David Perlin; Claude P Selitrennikoff
Studies of the paradoxical effect of caspofungin at high drug concentrations.
Diagnostic microbiology and infectious disease 2005;51(3):173-8.
2005: Karl V Clemons; William J Steinbach; David W Denning; David A Stevens
Advances against aspergillosis (September 9-11, 2004, San Francisco, California).
Mycopathologia 2005;159(2):315-7.
2004: Jackie K Imai; Gaurav Singh; Karl V Clemons; David A Stevens
Efficacy of posaconazole in a murine model of central nervous system aspergillosis.
Antimicrobial agents and chemotherapy 2004;48(10):4063-6.
2004: David A Stevens; Marife Espiritu; Rachana Parmar
Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.
Antimicrobial agents and chemotherapy 2004;48(9):3407-11.
2004: Karl V Clemons; Jimmy Spearow; Rachana Parmar; Marife Espiritu; David A Stevens
Genetic susceptibility of mice to Candida albicans vaginitis correlates with host estrogen sensitivity.
Infection and immunity 2004;72(8):4878-80.
2004: Michael J McCullough; Jacks J Jorge; Flavio Lejbkowicz; Eli Lefler; Faris Nassar; Karl V Clemons; David A Stevens
Genotypic differences of Candida albicans and C. dubliniensis isolates related to ethnic/racial differences within the same geographic area.
Mycopathologia 2004;158(1):39-41.
2004: David A Stevens
Vaccinate against aspergillosis! A call to arms of the immune system.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(8):1131-6.
2004: Jung-Hyun Choi; Elmer Brummer; David A Stevens
Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus.
Microbes and infection / Institut Pasteur 2004;6(4):383-9.
2004: Claudia M L Maffei; Laurence F Mirels; Raymond A Sobel; Karl V Clemons; David A Stevens
Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.
Infection and immunity 2004;72(4):2338-49.
2004: Karl V Clemons; David A Stevens
Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosis.
Antimicrobial agents and chemotherapy 2004;48(3):1047-50.
2003: Jose G Montoya; Sandra Chaparro; D Celis; J A Cortés; Ann N Leung; R C Robbins; David A Stevens
Invasive aspergillosis in the setting of cardiac transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37 Suppl 3():S281-92.
2003: David A Stevens; Richard B Moss; Viswanath P Kurup; Alan P knutsen; Paul Greenberger; Marc A Judson; David W Denning; Reto Crameri; Alan S Brody; Michael Light; Marianne Skov; William Maish; Gianni Mastella
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37 Suppl 3():S225-64.
2003: William J Steinbach; David A Stevens; David W Denning
Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37 Suppl 3():S188-224.
2003: William J Steinbach; David A Stevens
Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37 Suppl 3():S157-87.
2003: William J Steinbach; David A Stevens; David W Denning; Richard B Moss
Advances against aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37 Suppl 3():S155-6.
2003: Stan Deresinski; David A Stevens
Caspofungin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(11):1445-57.
2003: Leilani Calderon; R Williams; Martha Martinez; Karl V Clemons; David A Stevens
Genetic susceptibility to vaginal candidiasis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2003;41(2):143-7.
2003: Javier Capilla Luque; Karl V Clemons; David A Stevens
Efficacy of micafungin alone or in combination against systemic murine aspergillosis.
Antimicrobial agents and chemotherapy 2003;47(4):1452-5.
2003: Tom M Chiller; John N Galgiani; David A Stevens
Coccidioidomycosis.
Infectious disease clinics of North America 2003;17(1):41-57, viii.
2003: Elmer Brummer; Marika Kamberi; David A Stevens
Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia.
The Journal of infectious diseases 2003;187(4):705-9.
2003: Perparim Kamberi; Raymond A Sobel; Karl V Clemons; David A Stevens; Demosthenes Pappagianis; Paul L Williams
A murine model of coccidioidal meningitis.
The Journal of infectious diseases 2003;187(3):453-60.
2003: Tom M Chiller; Raymond A Sobel; Javier Capilla Luque; Karl V Clemons; David A Stevens
Efficacy of amphotericin B or itraconazole in a murine model of central nervous system Aspergillus infection.
Antimicrobial agents and chemotherapy 2003;47(2):813-5.
2002: Paul L Williams; Stephen Leib; Perparim Kamberi; David Leppert; Raymond A Sobel; Yoeng-Delphine Bifrare; Karl V Clemons; David A Stevens
Levels of matrix metalloproteinase-9 within cerebrospinal fluid in a rabbit model of coccidioidal meningitis and vasculitis.
The Journal of infectious diseases 2002;186(11):1692-5.
2002: David A Stevens; Leilani Calderon; Martha Martinez; Karl V Clemons; Shelly J Wilson; Claude P Selitrennikoff
Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model.
The Journal of antimicrobial chemotherapy 2002;50(3):361-4.
2002: Tom M Chiller; Javier Capilla Luque; Raymond A Sobel; Kouros Farrokhshad; Karl V Clemons; David A Stevens
Development of a murine model of cerebral aspergillosis.
The Journal of infectious diseases 2002;186(4):574-7.
2002: Karl V Clemons; Raymond A Sobel; Paul L Williams; Demosthenes Pappagianis; David A Stevens
Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.
Antimicrobial agents and chemotherapy 2002;46(8):2420-6.
2002: Marika Kamberi; Elmer Brummer; David A Stevens
Regulation of bronchoalveolar macrophage proinflammatory cytokine production by dexamethasone and granulocyte-macrophage colony-stimulating factor after stimulation by Aspergillus conidia or lipopolysaccharide.
Cytokine 2002;19(1):14-20.
2002: Karl V Clemons; Tamara K Miller; Claude P Selitrennikoff; David A Stevens
fos-1, a putative histidine kinase as a virulence factor for systemic aspergillosis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2002;40(3):259-62.
2002: Theodore C White; Scott Holleman; Francis Dy; Laurence F Mirels; David A Stevens
Resistance mechanisms in clinical isolates of Candida albicans.
Antimicrobial agents and chemotherapy 2002;46(6):1704-13.
2002: Tige R Rustad; David A Stevens; Michael A Pfaller; Theodore C White
Homozygosity at the Candida albicans MTL locus associated with azole resistance.
Microbiology (Reading, England) 2002;148(Pt 4):1061-72.
2002: Karl V Clemons; Martha Martinez; Leilani Calderon; David A Stevens
Efficacy of ravuconazole in treatment of systemic murine histoplasmosis.
Antimicrobial agents and chemotherapy 2002;46(3):922-4.
2002: Elmer Brummer; Anjum Maqbool; David A Stevens
Protection of peritoneal macrophages by granulocyte/macrophage colony-stimulating factor (GM-CSF) against dexamethasone suppression of killing of Aspergillus, and the effect of human GM-CSF.
Microbes and infection / Institut Pasteur 2002;4(2):133-8.
2002: Tom M Chiller; K Farrokhshad; Elmer Brummer; David A Stevens
Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2002;40(1):21-6.
2002: David A Stevens
Diagnosis of fungal infections: current status.
The Journal of antimicrobial chemotherapy 2002;49 Suppl 1():11-9.
2001: Elmer Brummer; Anjum Maqbool; David A Stevens
Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2001;39(6):509-15.
2001: David A Stevens; S A Shatsky
Intrathecal amphotericin in the management of coccidioidal meningitis.
Seminars in respiratory infections 2001;16(4):263-9.
2001: Elmer Brummer; Anjum Maqbool; David A Stevens
In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages.
Journal of leukocyte biology 2001;70(6):868-72.
2001: Karl V Clemons; David A Stevens
Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice.
Antimicrobial agents and chemotherapy 2001;45(12):3433-6.
2001: John R Perfect; G M Cox; J Y Lee; Carol A Kauffman; L de Repentigny; Stanley W Chapman; V A Morrison; Paul Pappas; John W Hiemenz; David A Stevens
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(11):1824-33.
2001: S Khatami; Elmer Brummer; David A Stevens
Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells.
Clinical and experimental immunology 2001;125(2):198-201.
2001: John H Rex; THOMAS WALSH; Mary D Nettleman; Elias J Anaissie; JOHN BENNETT; E J Bow; A J Carillo-Munoz; Pascal Chavanet; Gretchen A Cloud; D W Denning; B E de Pauw; J E Edwards Jr; John W Hiemenz; Carol A Kauffman; G Lopez-Berestein; P Martino; Jack D Sobel; David A Stevens; R Sylvester; J Tollemar; C Viscoli; M A Viviani; T Wu
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(1):95-106.
2001: Karl V Clemons; D F Ranney; David A Stevens
A novel heparin-coated hydrophilic preparation of amphotericin B hydrosomes.
Current opinion in investigational drugs (London, England : 2000) 2001;2(4):480-7.
2001: K V Clemons; David A Stevens
Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy.
Seminars in respiratory infections 2001;16(1):60-6.
2001: Karl V Clemons; Jon E Lutz; David A Stevens
Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice.
Antimicrobial agents and chemotherapy 2001;45(3):686-9.
2001: Claude P Selitrennikoff; LA Alex; Tamara K Miller; Karl V Clemons; M I Simon; David A Stevens
COS-l, a putative two-component histidine kinase of Candida albicans, is an in vivo virulence factor.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2001;39(1):69-74.
2001: Tom M Chiller; K Farrokhshad; Elmer Brummer; David A Stevens
The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus.
Diagnostic microbiology and infectious disease 2001;39(2):99-103.
2001: Karl V Clemons; R A Sobel; P L Williams; David A Stevens
Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits.
Antimicrobial agents and chemotherapy 2001;45(2):612-5.
2001: Karl V Clemons; David A Stevens
Efficacy of the partricin derivative SPA-S-753 against systemic murine candidosis.
The Journal of antimicrobial chemotherapy 2001;47(2):183-6.
2001: Karl V Clemons; Jon E Lutz; David A Stevens
Efficacy of interferon-gamma and amphotericin B for the treatment of systemic murine histoplasmosis.
Microbes and infection / Institut Pasteur 2001;3(1):3-10.
2001: M Ahluwalia; Elmer Brummer; S Sridhar; R Singh; David A Stevens
Isolation and characterisation of an anticryptococcal protein in human cerebrospinal fluid.
Journal of medical microbiology 2001;50(1):83-9.
2000: A Ganer; Elmer Brummer; David A Stevens
Correlation of susceptibility of immature mice to fungal infection (blastomycosis) and effector cell function.
Infection and immunity 2000;68(12):6833-9.
2000: Tom M Chiller; K Farrokhshad; Elmer Brummer; David A Stevens
Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2000;44(12):3302-5.
2000: John N Galgiani; Antonino Catanzaro; Gretchen A Cloud; Royce H Johnson; Paul L Williams; Laurence F Mirels; F Nassar; Jon E Lutz; David A Stevens; P K Sharkey; V R Singh; Robert A Larsen; K L Delgado; C Flanigan; Michael G Rinaldi
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.
Annals of internal medicine 2000;133(9):676-86.
2000: Karl V Clemons; G Grunig; R A Sobel; Laurence F Mirels; Donna Rennick; David A Stevens
Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis.
Clinical and experimental immunology 2000;122(2):186-91.
2000: KN Sorensen; Raymond A Sobel; Karl V Clemons; Leilani Calderon; K J Howell; P R Irani; Demosthenes Pappagianis; Paul L Williams; David A Stevens
Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.
Antimicrobial agents and chemotherapy 2000;44(11):3087-91.
2000: Jon E Lutz; Karl V Clemons; David A Stevens
Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis.
The Journal of antimicrobial chemotherapy 2000;46(3):437-42.
2000: David A Stevens
Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens.
Antimicrobial agents and chemotherapy 2000;44(9):2547-8.
2000: Karl V Clemons; W C Darbonne; John T Curnutte; R A Sobel; David A Stevens
Experimental histoplasmosis in mice treated with anti-murine interferon-gamma antibody and in interferon-gamma gene knockout mice.
Microbes and infection / Institut Pasteur 2000;2(9):997-1001.
2000: Karl V Clemons; David A Stevens
Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis. p6.
Antimicrobial agents and chemotherapy 2000;44(7):1874-7.
2000: Karl V Clemons; David A Stevens
Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-gamma.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2000;38(3):213-9.
2000: KN Sorensen; Raymond A Sobel; Karl V Clemons; Demosthenes Pappagianis; David A Stevens; Paul L Williams
Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.
Antimicrobial agents and chemotherapy 2000;44(6):1512-7.
2000: S Sridhar; M Ahluwalia; Elmer Brummer; David A Stevens
Characterization of an anticryptococcal protein isolated from human serum.
Infection and immunity 2000;68(6):3787-91.
2000: John N Galgiani; Neil M Ampel; Antonino Catanzaro; Royce H Johnson; David A Stevens; Paul L Williams
Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(4):658-61.
2000: David A Stevens; H J Schwartz; J Y Lee; BL Moskovitz; D C Jerome; A Catanzaro; D M Bamberger; A J Weinmann; CU Tuazon; Marc A Judson; T A Platts-Mills; A C DeGraff
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
The New England journal of medicine 2000;342(11):756-62.
2000: H M Hagman; Ellen G Madnick; A N D'Agostino; Paul L Williams; S Shatsky; Laurence F Mirels; R M Tucker; Michael G Rinaldi; David A Stevens; Richard E Bryant
Hyphal forms in the central nervous system of patients with coccidioidomycosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(2):349-53.
2000: Michael J McCullough; A F DiSalvo; Karl V Clemons; P Park; David A Stevens
Molecular epidemiology of Blastomyces dermatitidis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(2):328-35.
2000: Karl V Clemons; R A Sobel; David A Stevens
Toxicity of LY303366, an echinocandin antifungal, in mice pretreated with glucocorticoids.
Antimicrobial agents and chemotherapy 2000;44(2):378-81.
1999: Michael J McCullough; Karl V Clemons; David A Stevens
Molecular epidemiology of the global and temporal diversity of Candida albicans.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(5):1220-5.
1999: A Polesky; Carl M Kirsch; L S Snyder; Philip A LoBue; Frank T Kagawa; B J Dykstra; John H Wehner; Antonino Catanzaro; Neil M Ampel; David A Stevens
Airway coccidioidomycosis--report of cases and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(6):1273-80.
1999: Raed O Abuodeh; Lisa F Shubitz; E Siegel; S Snyder; Tao Peng; kris orsborn; E Brummer; David A Stevens; John N Galgiani
Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
Infection and immunity 1999;67(6):2935-40.
1999: David A Stevens
Itraconazole in cyclodextrin solution.
Pharmacotherapy 1999;19(5):603-11.
1999: Elmer Brummer; S D Chauhan; David A Stevens
Collaboration of human phagocytes with LY 303366 for antifungal activity against Aspergillus fumigatus.
The Journal of antimicrobial chemotherapy 1999;43(4):491-6.
1999: Michael J McCullough; Karl V Clemons; David A Stevens
Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.
Journal of clinical microbiology 1999;37(2):417-21.
1999: K N Sorensen; Karl V Clemons; David A Stevens
Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.
Mycopathologia 1999;146(2):53-65.
1999: David A Stevens; David W Denning; S Shatsky; R W Armstrong; J D Adler; B H Lewis
Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications.
Mycopathologia 1999;146(1):1-8.
1998: Elmer Brummer; GL Gilmore; Richard K Shadduck; David A Stevens
Development of macrophage anticryptococcal activity in vitro is dependent on endogenous M-CSF.
Cellular immunology 1998;189(2):144-8.
1998: BH Aristizabal; Karl V Clemons; David A Stevens; Angela Restrepo
Morphological transition of Paracoccidioides brasiliensis conidia to yeast cells: in vivo inhibition in females.
Infection and immunity 1998;66(11):5587-91.
1998: Paul L Williams; Raymond A Sobel; KN Sorensen; Karl V Clemons; L M Shuer; S S Royaltey; Y Yao; Demosthenes Pappagianis; Jon E Lutz; C Reed; M E River; B C Lee; S U Bhatti; David A Stevens
A model of coccidioidal meningoencephalitis and cerebrospinal vasculitis in the rabbit.
The Journal of infectious diseases 1998;178(4):1217-21.
1998: S Vora; S Chauhan; Elmer Brummer; David A Stevens
Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Antimicrobial agents and chemotherapy 1998;42(9):2299-303.
1998: Michael J McCullough; Karl V Clemons; John H McCusker; David A Stevens
Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).
Journal of clinical microbiology 1998;36(9):2613-7.
1998: Elizabeth A Winzeler; Daniel R Richards; AR Conway; Alan L Goldstein; Sue Kalman; Michael J McCullough; John H McCusker; David A Stevens; Lisa M Wodicka; David J Lockhart; Ronald W Davis
Direct allelic variation scanning of the yeast genome.
Science (New York, N.Y.) 1998;281(5380):1194-7.
1998: Michael J McCullough; Karl V Clemons; A Del Palacio; David A Stevens
Epidemiology of Candida albicans isolates from heroin addicts analysed by DNA typing.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(4):213-7.
1998: David A Stevens
Combination immunotherapy and antifungal chemotherapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(6):1266-9.
1998: U Natarajan; N Randhawa; Elmer Brummer; David A Stevens
Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
Journal of medical microbiology 1998;47(4):359-63.
1998: S Vora; N Purimetla; Elmer Brummer; David A Stevens
Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Antimicrobial agents and chemotherapy 1998;42(4):907-10.
1998: K V Clemons; David A Stevens
Comparison of fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis.
Antimicrobial agents and chemotherapy 1998;42(4):899-902.
1998: Michael J McCullough; Karl V Clemons; John H McCusker; David A Stevens
Intergenic transcribed spacer PCR ribotyping for differentiation of Saccharomyces species and interspecific hybrids.
Journal of clinical microbiology 1998;36(4):1035-8.
1998: Michael J McCullough; Karl V Clemons; C Farina; John H McCusker; David A Stevens
Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method.
Journal of clinical microbiology 1998;36(2):557-62.
1998: S Duvvuru; Elmer Brummer; R Morelli; David A Stevens
Isolation of a human serum protein that inhibits the growth of Cryptococcus neoformans.
Mycopathologia 1998;144(1):1-7.
1997: David A Stevens; BH Aristizabal
In vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746 and UR-9751, and comparison with fluconazole.
Diagnostic microbiology and infectious disease 1997;29(2):103-6.
1997: David A Stevens; J Y Lee
Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.
Archives of internal medicine 1997;157(16):1857-62.
1997: David A Stevens; Elmer Brummer; A F DiSalvo; A Ganer
Virulent isolates and mutants of Blastomyces in mice: a legacy for studies of pathogenesis.
Seminars in respiratory infections 1997;12(3):189-95.
1997: David A Stevens; M Diaz; R Negroni; F Montero-Gei; L G Castro; S A Sampaio; D Borelli; A Restrepo; L Franco; J L Bran; E G Arathoon
Safety evaluation of chronic fluconazole therapy. Fluconazole Pan-American Study Group.
Chemotherapy 1997;43(5):371-7.
1997: K V Clemons; David A Stevens
Efficacy of nikkomycin Z against experimental pulmonary blastomycosis.
Antimicrobial agents and chemotherapy 1997;41(9):2026-8.
1997: U Natarajan; Elmer Brummer; David A Stevens
Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole.
Antimicrobial agents and chemotherapy 1997;41(7):1575-8.
1997: Jon E Lutz; Karl V Clemons; BH Aristizabal; David A Stevens
Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
Antimicrobial agents and chemotherapy 1997;41(7):1558-61.
1997: Karl V Clemons; P Park; John H McCusker; Michael J McCullough; Ronald W Davis; David A Stevens
Application of DNA typing methods and genetic analysis to epidemiology and taxonomy of Saccharomyces isolates.
Journal of clinical microbiology 1997;35(7):1822-8.
1997: K V Clemons; F Feroze; K Holmberg; David A Stevens
Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods.
Journal of clinical microbiology 1997;35(6):1332-6.
1997: Y Minn; Elmer Brummer; David A Stevens
Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages.
Mycopathologia 1997;138(1):29-35.
1997: Karl V Clemons; David A Stevens
Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.
Antimicrobial agents and chemotherapy 1997;41(1):200-3.
1996: David A Stevens; J A Stevens
Cross-resistance phenotypes of fluconazole-resistant Candida species: results with 655 clinical isolates with different methods.
Diagnostic microbiology and infectious disease 1996;26(3-4):145-8.
1996: S Gujral; Elmer Brummer; David A Stevens
Role of extended culture time on synergy of fluconazole and human monocyte-derived macrophages in clearing Candida albicans.
The Journal of infectious diseases 1996;174(4):888-90.
1996: Karl V Clemons; R Azzi; David A Stevens
Experimental systemic cryptococcosis in SCID mice.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1996;34(5):331-5.
1996: Karl V Clemons; L C Hanson; David A Stevens
Colony phenotype switching in clinical and non-clinical isolates of Saccharomyces cerevisiae.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1996;34(4):259-64.
1996: Karl V Clemons; M Martinez; M E Homola; David A Stevens
Therapy of systemic histoplasmosis in immunosuppressed mice with the triazole D0870.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1996;34(4):241-6.
1996: J P Sison; Y Yao; Carol A Kemper; J R Hamilton; E Brummer; David A Stevens; Stan Deresinski
Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?
The Journal of infectious diseases 1996;173(3):750-3.
1996: J P Sison; Y Yao; Carol A Kemper; J R Hamilton; E Brummer; David A Stevens; Stan Deresinski
Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?
The Journal of infectious diseases 1996;173(3):677-83.
1996: A F Bañuelos; P L Williams; R H Johnson; S Bibi; D N Fredricks; S A Gilroy; S U Bhatti; J Aguet; David A Stevens
Central nervous system abscesses due to Coccidioides species.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(2):240-50.
1996: Elmer Brummer; David A Stevens
Synergy of human neutrophils with fluconazole in killing Candida species.
Mycopathologia 1996;134(3):115-20.
1996: D D Grover; Elmer Brummer; David A Stevens
Study of the role of iron in the anticryptococcal activity of human serum and fluconazole.
Mycopathologia 1996;133(2):71-7.
1995: U K Garcha; Elmer Brummer; David A Stevens
Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species.
The Journal of infectious diseases 1995;172(6):1620-3.
1995: F Nassar; Elmer Brummer; David A Stevens
Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity.
Antimicrobial agents and chemotherapy 1995;39(11):2490-3.
1995: Elmer Brummer; David A Stevens
Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum.
Clinical and experimental immunology 1995;102(1):65-70.
1995: L H Hanson; Karl V Clemons; D W Denning; David A Stevens
Efficacy of oral saperconazole in systemic murine aspergillosis.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1995;33(5):311-7.
1995: G Desai; F Nassar; Elmer Brummer; David A Stevens
Killing of Histoplasma capsulatum by macrophage colony stimulating factor-treated human monocyte-derived macrophages: role for reactive oxygen intermediates.
Journal of medical microbiology 1995;43(3):224-9.
1995: F Nassar; Elmer Brummer; David A Stevens
Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing.
Cellular immunology 1995;164(1):113-8.
1995: Stan Deresinski; Karl V Clemons; Carol A Kemper; K Roesch; B Walton; David A Stevens
Genotypic analysis of pseudoepidemic due to contamination of Hanks' balanced salt solution with Candida parapsilosis.
Journal of clinical microbiology 1995;33(8):2224-6.
1995: Karl V Clemons; M E Homola; David A Stevens
Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Antimicrobial agents and chemotherapy 1995;39(5):1169-72.
1995: David A Stevens
Coccidioidomycosis.
The New England journal of medicine 1995;332(16):1077-82.
1995: Karl V Clemons; David A Stevens
Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis.
Antimicrobial agents and chemotherapy 1995;39(3):778-80.
1995: J K Byron; Karl V Clemons; John H McCusker; Ronald W Davis; David A Stevens
Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.
Infection and immunity 1995;63(2):478-85.
1995: U K Garcha; Elmer Brummer; David A Stevens
Synergy of fluconazole with macrophages for antifungal activity against Candida albicans.
Mycopathologia 1995;132(3):123-8.
1995: S Khemani; Elmer Brummer; David A Stevens
In vivo and in vitro effects of macrophage colony-stimulating factor (M-CSF) on bronchoalveolar macrophages for antihistoplasmal activity.
International journal of immunopharmacology 1995;17(1):49-53.
1995: K Kamei; Elmer Brummer; Karl V Clemons; David A Stevens
Induction of novel protein synthesis by opsonized Histoplasma capsulatum ingested by murine peritoneal macrophages.
Mycopathologia 1995;129(2):65-72.
1994: A W Husari; William A Jensen; Carl M Kirsch; A C Campagna; Frank T Kagawa; K A Hamed; R L Azzi; David A Stevens
Pulmonary mucormycosis presenting as an endobronchial lesion.
Chest 1994;106(6):1889-91.
1994: John H McCusker; Karl V Clemons; David A Stevens; Ronald W Davis
Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae.
Infection and immunity 1994;62(12):5447-55.
1994: David A Stevens
Management of systemic manifestations of fungal disease in patients with AIDS.
Journal of the American Academy of Dermatology 1994;31(3 Pt 2):S64-7.
1994: F Nassar; Elmer Brummer; David A Stevens
Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 1994;38(9):2162-4.
1994: Elmer Brummer; F Nassar; David A Stevens
Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing.
Antimicrobial agents and chemotherapy 1994;38(9):2158-61.
1994: Elmer Brummer; David A Stevens
Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, phagocytosis, and L-arginine.
Cellular immunology 1994;157(1):1-10.
1994: David A Stevens
Overview of amphotericin B colloidal dispersion (amphocil).
The Journal of infection 1994;28 Suppl 1():45-9.
1994: Karl V Clemons; John H McCusker; R W Davis; David A Stevens
Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae.
The Journal of infectious diseases 1994;169(4):859-67.
1994: L E Cano; Beatriz L Gomez; E Brummer; Angela Restrepo; David A Stevens
Inhibitory effect of deferoxamine or macrophage activation on transformation of Paracoccidioides brasiliensis conidia ingested by macrophages: reversal by holotransferrin.
Infection and immunity 1994;62(4):1494-6.
1994: John H McCusker; Karl V Clemons; David A Stevens; Ronald W Davis
Genetic characterization of pathogenic Saccharomyces cerevisiae isolates.
Genetics 1994;136(4):1261-9.
1994: Karl V Clemons; Elmer Brummer; David A Stevens
Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis.
Antimicrobial agents and chemotherapy 1994;38(3):460-4.
1994: Elmer Brummer; David A Stevens
Effect of macrophage colony-stimulating factor (M-CSF) on macrophage morphology, phagocytosis, and intracellular multiplication of Histoplasma capsulatum.
International journal of immunopharmacology 1994;16(2):171-6.
1994: J S Hostetler; A Catanzaro; David A Stevens; John Graybill; P K Sharkey; R A Larsen; R M Tucker; A D al-Haidary; Michael G Rinaldi; Gretchen A Cloud
Treatment of coccidioidomycosis with SCH 39304.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32(2):105-14.
1994: D H Dewsnup; David A Stevens
Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32(5):389-93.
1994: David A Stevens; J E Domer; R B Ashman; R Blackstock; Elmer Brummer
Immunomodulation in mycoses.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32 Suppl 1():253-65.
1993: G S Heinic; David A Stevens; Deborah Greenspan; Laurie MacPhail; C L Dodd; S Stringari; W M Strull; H Hollander
Fluconazole-resistant Candida in AIDS patients. Report of two cases.
Oral surgery, oral medicine, and oral pathology 1993;76(6):711-5.
1993: J S Hostetler; Elmer Brummer; R L Coffman; David A Stevens
Effect of anti-IL-4, interferon-gamma and an antifungal triazole (SCH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome.
Clinical and experimental immunology 1993;94(1):11-6.
1993: J S Hostetler; J Heykants; Karl V Clemons; R Woestenborghs; L H Hanson; David A Stevens
Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations.
Antimicrobial agents and chemotherapy 1993;37(10):2224-7.
1993: Karl V Clemons; David A Stevens
Therapeutic efficacy of a liposomal formulation of amphotericin B (AmBisome) against murine blastomycosis.
The Journal of antimicrobial chemotherapy 1993;32(3):465-72.
1993: J S Hostetler; L H Hanson; David A Stevens
Effect of hydroxypropyl-beta-cyclodextrin on efficacy of oral itraconazole in disseminated murine cryptococcosis.
The Journal of antimicrobial chemotherapy 1993;32(3):459-63.
1993: Carol A Kemper; J S Hostetler; S E Follansbee; P Ruane; D Covington; S S Leong; Stan Deresinski; David A Stevens
Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(3):344-52.
1993: Elmer Brummer; L H Hanson; David A Stevens
IL-4, IgE, and interferon-gamma production in pulmonary blastomycosis: comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304).
Cellular immunology 1993;149(2):258-67.
1993: Karl V Clemons; L H Hanson; David A Stevens
Activities of the triazole D0870 in vitro and against murine blastomycosis.
Antimicrobial agents and chemotherapy 1993;37(5):1177-9.
1993: L G Castro; W Belda Júnior; L C Cucé; S A Sampaio; David A Stevens
Successful treatment of sporotrichosis with oral fluconazole: a report of three cases.
The British journal of dermatology 1993;128(3):352-6.
1992: J S Hostetler; Karl V Clemons; L H Hanson; David A Stevens
Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis.
Antimicrobial agents and chemotherapy 1992;36(12):2656-60.
1992: Elmer Brummer; P R Bhagavathula; L H Hanson; David A Stevens
Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
Antimicrobial agents and chemotherapy 1992;36(11):2487-92.
1992: Karl V Clemons; David A Stevens
Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis.
The Journal of antimicrobial chemotherapy 1992;30(3):353-63.
1992: L E Cano; E Brummer; David A Stevens; Angela Restrepo
Fate of conidia of Paracoccidioides brasiliensis after ingestion by resident macrophages or cytokine-treated macrophages.
Infection and immunity 1992;60(5):2096-100.
1992: L H Hanson; David A Stevens
Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion.
Antimicrobial agents and chemotherapy 1992;36(2):486-8.
1992: J S Hostetler; L H Hanson; David A Stevens
Effect of cyclodextrin on the pharmacology of antifungal oral azoles.
Antimicrobial agents and chemotherapy 1992;36(2):477-80.
1992: L E Cano; R Arango; M E Salazar; E Brummer; David A Stevens; Angela Restrepo
Killing of Paracoccidioides brasiliensis conidia by pulmonary macrophages and the effect of cytokines.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30(2):161-8.
1992: K Kamei; Elmer Brummer; Karl V Clemons; David A Stevens
Induction of stress protein synthesis in Histoplasma capsulatum by heat, low pH and hydrogen peroxide.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30(5):385-93.
1992: J S Hostetler; D W Denning; David A Stevens
US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host.
Chemotherapy 1992;38 Suppl 1():12-22.
1992: R M Tucker; D W Denning; L H Hanson; Michael G Rinaldi; John Graybill; P K Sharkey; Demosthenes Pappagianis; David A Stevens
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(1):165-74.
1992: D W Denning; L H Hanson; A M Perlman; David A Stevens
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
Diagnostic microbiology and infectious disease 1992;15(1):21-34.
1992: D W Denning; Karl V Clemons; David A Stevens
Quantitative preservation of viability of Aspergillus fumigatus.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30(6):485-8.
1991: David A Stevens; S I Greene; O S Lang
Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
Archives of internal medicine 1991;151(12):2458-64.
1991: J S Hostetler; David A Stevens
[The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
Medizinische Klinik (Munich, Germany : 1983) 1991;86 Suppl 1():8-10.
1991: D W Denning; R W Armstrong; M Fishman; David A Stevens
Endophthalmitis in a patient with disseminated cryptococcosis and AIDS who was treated with itraconazole.
Reviews of infectious diseases 1991;13(6):1126-30.
1991: Karl V Clemons; David A Stevens
Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis.
Antimicrobial agents and chemotherapy 1991;35(10):2144-6.
1991: Karl V Clemons; David A Stevens
Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis.
Antimicrobial agents and chemotherapy 1991;35(9):1829-33.
1991: D W Denning; R W Armstrong; B H Lewis; David A Stevens
Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome.
The American journal of medicine 1991;91(3):267-72.
1991: D W Denning; J E Van Wye; N J Lewiston; David A Stevens
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
Chest 1991;100(3):813-9.
1991: Christine Morrison; David A Stevens
Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates.
Infection and immunity 1991;59(8):2744-9.
1991: L H Hanson; A M Perlman; Karl V Clemons; David A Stevens
Synergy between cilofungin and amphotericin B in a murine model of candidiasis.
Antimicrobial agents and chemotherapy 1991;35(7):1334-7.
1991: D W Denning; David A Stevens
Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.
Antimicrobial agents and chemotherapy 1991;35(7):1329-33.
1991: Susan K Keay; D W Denning; David A Stevens
Endocarditis due to Trichosporon beigelii: in vitro susceptibility of isolates and review.
Reviews of infectious diseases 1991;13(3):383-6.
1991: Elmer Brummer; L H Hanson; David A Stevens
SCH 39304 in the treatment of acute or established murine pulmonary blastomycosis.
Antimicrobial agents and chemotherapy 1991;35(4):788-90.
1991: D W Denning; S E Follansbee; M Scolaro; S Norris; H Edelstein; David A Stevens
Pulmonary aspergillosis in the acquired immunodeficiency syndrome.
The New England journal of medicine 1991;324(10):654-62.
1991: R M Tucker; J R Hamilton; David A Stevens
Concurrent bloodstream infection with Histoplasma capsulatum and Mycobacterium tuberculosis.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1991;29(5):343-5.
1991: D W Denning; Gillian Shankland; David A Stevens
DNA fingerprinting of Aspergillus fumigatus isolates from patients with aspergilloma.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1991;29(5):339-42.
1991: Karl V Clemons; S M Hurley; L G Treat-Clemons; David A Stevens
Variable colonial phenotypic expression and comparison to nuclei number in Blastomyces dermatitidis.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1991;29(3):165-77.
1991: Elmer Brummer; L H Hanson; David A Stevens
Kinetics and requirements for activation of macrophages for fungicidal activity: effect of protein synthesis inhibitors and immunosuppressants on activation and fungicidal mechanism.
Cellular immunology 1991;132(1):236-45.
1991: Karl V Clemons; Gillian Shankland; M D Richardson; David A Stevens
Epidemiologic study by DNA typing of a Candida albicans outbreak in heroin addicts.
Journal of clinical microbiology 1991;29(1):205-7.
1990: Carol A Kemper; R M Tucker; O S Lang; J M Kessinger; S I Greene; Stan Deresinski; David A Stevens
Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex.
AIDS (London, England) 1990;4(11):1145-8.
1990: D W Denning; David A Stevens
Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.
Reviews of infectious diseases 1990;12(6):1147-201.
1990: D W Denning; Karl V Clemons; L H Hanson; David A Stevens
Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin.
The Journal of infectious diseases 1990;162(5):1151-8.
1990: R M Tucker; Y Haq; D W Denning; David A Stevens
Adverse events associated with itraconazole in 189 patients on chronic therapy.
The Journal of antimicrobial chemotherapy 1990;26(4):561-6.
1990: E G Arathoon; J R Hamilton; C E Hench; David A Stevens
Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates.
Antimicrobial agents and chemotherapy 1990;34(9):1655-9.
1990: D W Denning; L H Hanson; David A Stevens
In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(9):693-7.
1990: D W Denning; R M Tucker; L H Hanson; David A Stevens
Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
Journal of the American Academy of Dermatology 1990;23(3 Pt 2):602-7.
1990: R M Tucker; D W Denning; E G Arathoon; Michael G Rinaldi; David A Stevens
Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Journal of the American Academy of Dermatology 1990;23(3 Pt 2):593-601.
1990: P K Sharkey; John Graybill; Michael G Rinaldi; David A Stevens; R M Tucker; J D Peterie; P D Hoeprich; D L Greer; L Frenkel; G W Counts
Itraconazole treatment of phaeohyphomycosis.
Journal of the American Academy of Dermatology 1990;23(3 Pt 2):577-86.
1990: David A Stevens
Fungal infections in AIDS patients.
British journal of clinical practice. Supplement 1990;71():11-22.
1990: Elmer Brummer; S H Sun; J L Harrison; A M Perlman; D E Philpott; David A Stevens
Ultrastructure of phagocytosed Paracoccidioides brasiliensis in nonactivated or activated macrophages.
Infection and immunity 1990;58(8):2628-36.
1990: Karl V Clemons; L H Hanson; A M Perlman; David A Stevens
Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.
Antimicrobial agents and chemotherapy 1990;34(5):928-30.
1990: Christine Morrison; David A Stevens
Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
Antimicrobial agents and chemotherapy 1990;34(5):746-50.
1990: David A Stevens; Elmer Brummer; J G McEwen; A M Perlman
Comparison of fluconazole and ketoconazole in experimental murine blastomycosis.
Reviews of infectious diseases 1990;12 Suppl 3():S304-6.
1990: David A Stevens; F C Odds; S Scherer
Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype.
Reviews of infectious diseases 1990;12(2):258-66.
1990: Elmer Brummer; A Restrepo; L H Hanson; David A Stevens
Virulence of Paracoccidiodes brasiliensis: the influence of in vitro passage and storage.
Mycopathologia 1990;109(1):13-7.
1989: D W Denning; R M Tucker; L H Hanson; J R Hamilton; David A Stevens
Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
Archives of internal medicine 1989;149(10):2301-8.
1989: Christine Morrison; Elmer Brummer; David A Stevens
In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing.
Infection and immunity 1989;57(10):2953-8.
1989: L H Hanson; David A Stevens
Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens.
Antimicrobial agents and chemotherapy 1989;33(8):1391-2.
1989: Elmer Brummer; L H Hanson; A Restrepo; David A Stevens
Intracellular multiplication of Paracoccidioides brasiliensis in macrophages: killing and restriction of multiplication by activated macrophages.
Infection and immunity 1989;57(8):2289-94.
1989: Karl V Clemons; E P Stover; G Schär; P A Stathis; K Chan; L Tökès; David A Stevens; David Feldman
Steroid metabolism as a mechanism of escape from progesterone-mediated growth inhibition in Trichophyton mentagrophytes.
The Journal of biological chemistry 1989;264(19):11186-92.
1989: D W Denning; R M Tucker; L H Hanson; David A Stevens
Treatment of invasive aspergillosis with itraconazole.
The American journal of medicine 1989;86(6 Pt 2):791-800.
1989: R M Tucker; L H Hanson; Elmer Brummer; David A Stevens
Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.
Antimicrobial agents and chemotherapy 1989;33(4):573-5.
1989: Elmer Brummer; David A Stevens
Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon.
Journal of medical microbiology 1989;28(3):173-81.
1989: David A Stevens
The interface of mycology and endocrinology.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1989;27(3):133-40.
1989: Christine Morrison; David A Stevens
Enhanced killing of Blastomyces dermatitidis by gamma interferon-activated murine peripheral blood polymorphonuclear neutrophils.
International journal of immunopharmacology 1989;11(8):855-62.
1988: David A Stevens
The new generation of antifungal drugs.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1988;7(6):732-5.
1988: E Castaneda; Elmer Brummer; Demosthenes Pappagianis; David A Stevens
Regulation of immune responses by T suppressor cells and by serum in chronic paracoccidioidomycosis.
Cellular immunology 1988;117(1):1-11.
1988: Karl V Clemons; G Schär; E P Stover; David Feldman; David A Stevens
Dermatophyte-hormone relationships: characterization of progesterone-binding specificity and growth inhibition in the genera Trichophyton and Microsporum.
Journal of clinical microbiology 1988;26(10):2110-5.
1988: E Castaneda; Elmer Brummer; Demosthenes Pappagianis; David A Stevens
Impairment of cellular but not humoral immune responses in chronic pulmonary and disseminated paracoccidioidomycosis in mice.
Infection and immunity 1988;56(7):1771-7.
1988: Elmer Brummer; L H Hanson; A Restrepo; David A Stevens
In vivo and in vitro activation of pulmonary macrophages by IFN-gamma for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2786-9.
1988: M E Salazar; Angela Restrepo; David A Stevens
Inhibition by estrogens of conidium-to-yeast conversion in the fungus Paracoccidioides brasiliensis.
Infection and immunity 1988;56(3):711-3.
1988: R M Tucker; P L Williams; E G Arathoon; B E Levine; A I Hartstein; L H Hanson; David A Stevens
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.
Antimicrobial agents and chemotherapy 1988;32(3):369-73.
1988: Christine Morrison; R A Isenberg; David A Stevens
Enhanced oxidative mechanisms in immunologically activated versus elicited polymorphonuclear neutrophils: correlations with fungicidal activity.
Journal of medical microbiology 1988;25(2):115-21.
1988: John Graybill; David A Stevens; John N Galgiani; A M Sugar; P C Craven; C Gregg; M Huppert; Gretchen A Cloud; William E Dismukes
Ketoconazole treatment of coccidioidal meningitis.
Annals of the New York Academy of Sciences 1988;544():488-96.
1988: Elmer Brummer; L H Hanson; David A Stevens
Gamma-interferon activation of macrophages for killing of Paracoccidioides brasiliensis and evidence for nonoxidative mechanisms.
International journal of immunopharmacology 1988;10(8):945-52.
1988: E Castaneda; Elmer Brummer; A M Perlman; J G McEwen; David A Stevens
A culture medium for Paracoccidioides brasiliensis with high plating efficiency, and the effect of siderophores.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1988;26(6):351-8.
1988: R M Tucker; P L Williams; E G Arathoon; David A Stevens
Treatment of mycoses with itraconazole.
Annals of the New York Academy of Sciences 1988;544():451-70.
1987: E Castaneda; Elmer Brummer; Demosthenes Pappagianis; David A Stevens
Chronic pulmonary and disseminated paracoccidioidomycosis in mice: quantitation of progression and chronicity.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1987;25(6):377-87.
1987: A M Sugar; S G Alsip; John N Galgiani; John Graybill; William E Dismukes; Gretchen A Cloud; P C Craven; David A Stevens
Pharmacology and toxicity of high-dose ketoconazole.
Antimicrobial agents and chemotherapy 1987;31(12):1874-8.
1987: Elmer Brummer; David A Stevens
Fungicidal mechanisms of activated macrophages: evidence for nonoxidative mechanisms for killing of Blastomyces dermatitidis.
Infection and immunity 1987;55(12):3221-4.
1987: Elmer Brummer; David A Stevens
Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines.
Clinical and experimental immunology 1987;70(3):520-8.
1987: Christine Morrison; Elmer Brummer; David A Stevens
Effect of a local immune reaction on peripheral blood polymorphonuclear neutrophil microbicidal function: studies with fungal targets.
Cellular immunology 1987;110(1):176-82.
1987: Christine Morrison; Elmer Brummer; R A Isenberg; David A Stevens
Activation of murine polymorphonuclear neutrophils for fungicidal activity by recombinant gamma interferon.
Journal of leukocyte biology 1987;41(5):434-40.
1986: G Schär; E P Stover; Karl V Clemons; David Feldman; David A Stevens
Progesterone binding and inhibition of growth in Trichophyton mentagrophytes.
Infection and immunity 1986;52(3):763-7.
1986: E P Stover; G Schär; Karl V Clemons; David A Stevens; David Feldman
Estradiol-binding proteins from mycelial and yeast-form cultures of Paracoccidioides brasiliensis.
Infection and immunity 1986;51(1):199-203.
1985: J G McEwen; G R Peters; T F Blaschke; Elmer Brummer; A M Perlman; A Restrepo; David A Stevens
Treatment of paracoccidioidomycosis with itraconazole in a murine model.
The Journal of tropical medicine and hygiene 1985;88(5):295-9.
1985: E Lefler; E Brummer; J G McEwen; G L Hoyos; Angela Restrepo; David A Stevens
Study of current and new drugs in a murine model of acute paracoccidioidomycosis.
The American journal of tropical medicine and hygiene 1985;34(1):134-40.
1984: Angela Restrepo; M E Salazar; L E Cano; E P Stover; D Feldman; David A Stevens
Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis.
Infection and immunity 1984;46(2):346-53.
1984: A Pont; John Graybill; P C Craven; John N Galgiani; William E Dismukes; R E Reitz; David A Stevens
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Archives of internal medicine 1984;144(11):2150-3.
1984: E Brummer; Angela Restrepo; David A Stevens; R Azzi; A M Gomez; G L Hoyos; J G McEwen; L E Cano; Catalina de Bedout
Murine model of paracoccidioidomycosis. Production of fatal acute pulmonary or chronic pulmonary and disseminated disease: immunological and pathological observations.
Journal of experimental pathology 1984;1(3):241-55.
1984: G L Hoyos; J G McEwen; E Brummer; E Castañeda; Angela Restrepo; David A Stevens
Chronic murine paracoccidioidomycosis: effect of ketoconazole on clearance of Paracoccidioides brasiliensis and immune response.
Sabouraudia 1984;22(5):419-26.
1983: William E Dismukes; A M Stamm; John Graybill; P C Craven; David A Stevens; R L Stiller; G A Sarosi; G Medoff; C R Gregg; H A Gallis; B T Fields; R L Marier; T A Kerkering; L G Kaplowitz; Gretchen A Cloud; C Bowles; S Shadomy
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.
Annals of internal medicine 1983;98(1):13-20.
1982: A Pont; P L Williams; S Azhar; R E Reitz; C Bochra; E R Smith; David A Stevens
Ketoconazole blocks testosterone synthesis.
Archives of internal medicine 1982;142(12):2137-40.
1982: A Pont; P L Williams; D S Loose; D Feldman; R E Reitz; C Bochra; David A Stevens
Ketoconazole blocks adrenal steroid synthesis.
Annals of internal medicine 1982;97(3):370-2.
1982: Angela Restrepo; L E Cano; Catalina de Bedout; E Brummer; David A Stevens
Comparison of various techniques for determining viability of Paracoccidioides brasiliensis yeast-form cells.
Journal of clinical microbiology 1982;16(1):209-11.
1977: David A Stevens
Miconazole in coccidioidomycosis.
The Western journal of medicine 1977;126(4):315-6.